Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2025 · 10-Q
Revenue$2.52M$2.52M+39.4% vs Q3 2024 Net Income-$12.71M-$12.71MN/M vs Q3 2024 EPS Diluted-$0.17-$0.17N/M vs Q3 2024 Gross Profit$864,000+108.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$8,633,000N/M Free Cash Flowderived-$8,962,000N/M Margins · derivedGross margin34.2%+11.4 pt vs Q3 2024
Operating margin-517.3%−49.8 pt vs Q3 2024
Net margin-503.7%−67.8 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 10, 2025 · 41 d after period end